Citations

Mayo Clinic

Showing 10 of 108572 citations.

Adapting Conceptual Frameworks for Patient Engagement in Emergency Department Research
Carden, Donna L., Booker‐Vaughns, Juanita , Dunn, Patrick , Kizzie-Gillett, Constance L., Vaughan, William P., Weingarten, Gail, Williams, Pluscedia, Young‐Brinn, Angela, Grudzen, Corita R. , Wright, Rebecca , Hess, Erik P.

Academic Emergency Medicine | August 16, 2016 | Volume: 23 | Issue: 12 | Pages: 1332-1336

10.1111/acem.13066 | PMID 27526646 Get It

AbstractFor many people the emergency department (ED) is the first point of access to healthcare for acute needs and a recurring location for many with chronic healthcare needs. While the ED is well placed to identify unmet needs it can also be a net that people slip through when faced with uncoordinated and expensive healthcare challenges. Thus the ED has a responsibility to set patients on a safe and meaningful care trajectory, which can only be done in consultation and partnership with the patients themselves. The purpose of this article is to present crucial aspects of patient engagement that are essential for future research to foster an environment of colearning and respect that encourages ongoing involvement by patients, families, and staff.
Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment
Gertz, Morie A.

American Journal of Hematology | August 16, 2016 | Volume: 91 | Issue: 9 | Pages: 947-956

10.1002/ajh.24433 | PMID 27527836 Get It

Disease OverviewImmunoglobulin light chain amyloidosis is a clonal, nonproliferative plasma cell disorder in which fragments of immunoglobulin light chain are deposited in tissues. Clinical features depend on organs involved but can include restrictive cardiomyopathy, nephrotic syndrome, hepatic failure, peripheral/autonomic neuropathy, and atypical multiple myeloma.DiagnosisTissue biopsy stained with Congo red demonstrating amyloid deposits with applegreen birefringence is required for diagnosis. Invasive organ biopsy is not required because amyloid deposits can be found in bone marrow biopsy or subcutaneous fat aspirate in 85% of patients. Verification that amyloid is composed of immunoglobulin light chains is mandatory.PrognosisN‐terminal pro–brain natriuretic peptide (NTproBNP), serum troponin T, and difference between involved and uninvolved immunoglobulin free light chain values are used to classify patients into four groups of similar size; median survivals are 94.1, 40.3, 14.0, and 5.8 months.TherapyAll patients with a systemic amyloid syndrome require therapy to prevent deposition of amyloid in other organs and prevent progressive organ failure of involved sites. Stem cell transplant (SCT) is preferred, but only 20% of patients are eligible. Requirements for safe SCT include systolic blood pressure >90 mmHg, troponin T <0.06 ng mL21, age <70 years, and serum creatinine 1.7 mg dL21. Nontransplant candidates can be offered melphalan‐dexamethasone or cyclophosphamide‐bortezomib‐dexamethasone. Other combinations of chemotherapy with agents such as cyclophosphamide‐thalidomide (or lenalidomide)‐dexamethasone, bortezomib‐dexamethasone, and melphalan‐prednisone‐lenalidomide have documented activity. Antibodies designed to dissolve existing amyloid deposits are under study for previously treated and untreated patients. Late diagnosis remains a major obstacle to initiating effective therapy. Am. J. Hematol., 2016. © 2016 Wiley Periodicals, Inc. Am. J. Hematol. 91:948–956, 2016. © 2016 Wiley Periodicals, Inc.
Functional characterization of a GFAP variant of uncertain significance in an Alexander disease case within the setting of an individualized medicine clinic
Boczek, Nicole J. , Sigafoos, Ashley N. , Maus, Rachel L.G., Cousin, Margot A. , Blackburn, Patrick R. , Patterson, Marc C. , Wick, Myra , Klee, Eric W. , Zimmermann, Michael T. , Maus, Rachel L, Urrutia, Raúl , Clark, Karl J. , Wick, Myra J, Patterson, Marc

Clinical Case Reports | August 16, 2016 | Volume: 4 | Issue: 9 | Pages: 885-895

10.1002/ccr3.655 | PMID 27648269 Get It

Key Clinical MessageA de novo GFAP variant, p.R376W, was identified in a child presenting with hypotonia, developmental delay, and abnormal brain MRI. Following the 2015 ACMG variant classification guidelines and the functional studies showing protein aggregate formation in vitro, p.R376W should be classified as a pathogenic variant, causative for Alexander disease.
Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer
André, Thierry , Sargent, Daniel J. , Grothey, Axel , André, Thierry

Journal of Clinical Oncology | August 16, 2016 | Volume: 34 | Issue: 30 | Pages: 3711-3712

10.1200/jco.2016.68.4886 | PMID 27528725 Get It

Statistical Methods for Testing Genetic Pleiotropy
Schaid, Daniel J. , Tong, Xingwei, Larrabee, Beth R. , Kennedy, Richard B. , Sinnwell, Jason P. , Larrabee, Beth, Poland, Gregory A. , Sinnwell, Jason P , Kennedy, Richard

Genetics | August 16, 2016 | Volume: 204 | Issue: 2 | Pages: 483-497

10.1534/genetics.116.189308 | PMID 27527515 Get It

AbstractGenetic pleiotropy is when a single gene influences more than one trait. Detecting pleiotropy and understanding its causes can improve the biological understanding of a gene in multiple ways, yet current multivariate methods to evaluate pleiotropy test the null hypothesis that none of the traits are associated with a variant; departures from the null could be driven by just one associated trait. A formal test of pleiotropy should assume a null hypothesis that one or no traits are associated with a genetic variant. For the special case of two traits, one can construct this null hypothesis based on the intersection-union (IU) test, which rejects the null hypothesis only if the null hypotheses of no association for both traits are rejected. To allow for more than two traits, we developed a new likelihood-ratio test for pleiotropy. We then extended the testing framework to a sequential approach to test the null hypothesis that k+1 traits are associated, given that the null of k traits are associated was rejected. This provides a formal testing framework to determine the number of traits associated with a genetic variant, while accounting for correlations among the traits. By simulations, we illustrate the type I error rate and power of our new methods; describe how they are influenced by sample size, the number of traits, and the trait correlations; and apply the new methods to multivariate immune phenotypes in response to smallpox vaccination. Our new approach provides a quantitative assessment of pleiotropy, enhancing current analytic practice.
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
Tendulkar, Rahul D. , Agrawal, Shree , Gao, Tianming , Pisansky, Thomas M. , Michalski, Jeff M. , Hamstra, Daniel A. , Feng, Felix Y. , Liauw, Stanley L. , Abramowitz, Matthew C. , Pollack, Alan , Den, Robert B. , Stephans, Kevin L. , Zietman, Anthony L., Lee, W. Robert , Kattan, Michael W. , Stephenson, Andrew J. , Efstathiou, Jason A. , Koontz, Bridget F, Anscher, Mitchell S. , Moghanaki, Drew, Koontz, Bridget F. , Moghanaki, Drew M. , Den, Robert B , Liauw, Stanley L , Abramowitz, Matthew C , Kattan, Michael W

Journal of Clinical Oncology | August 15, 2016 | Volume: 34 | Issue: 30 | Pages: 3648-3654

10.1200/jco.2016.67.9647 | PMID 27528718 Get It

Purpose We aimed to update a previously published, multi-institutional nomogram of outcomes for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate cancer, including patients treated in the contemporary era. Methods Individual data from node-negative patients with a detectable post-RP prostate-specific antigen (PSA) treated with SRT with or without concurrent androgen-deprivation therapy (ADT) were obtained from 10 academic institutions. Freedom from biochemical failure (FFBF) and distant metastases (DM) rates were estimated, and predictive nomograms were generated. Results Overall, 2,460 patients with a median follow-up of 5 years were included; 599 patients (24%) had a Gleason score (GS) ≤ 6, 1,387 (56%) had a GS of 7, 244 (10%) had a GS of 8, and 230 (9%) had a GS of 9 to 10. There were 1,370 patients (56%) with extraprostatic extension (EPE), 452 (18%) with seminal vesicle invasion (SVI), 1,434 (58%) with positive surgical margins, and 390 (16%) who received ADT (median, 6 months). The median pre-SRT PSA was 0.5 ng/mL (interquartile range, 0.3 to 1.1). The 5-yr FFBF rate was 56% overall, 71% for those with a pre-SRT PSA level of 0.01 to 0.2 ng/mL (n = 441), 63% for those with a PSA of 0.21 to 0.50 ng/mL (n = 822), 54% for those with a PSA of 0.51 to 1.0 ng/mL (n = 533), 43% for those with a PSA of 1.01 to 2.0 ng/mL (n = 341), and 37% for those with a PSA > 2.0 ng/mL (n = 323); P < .001. On multivariable analysis, pre-SRT PSA, GS, EPE, SVI, surgical margins, ADT use, and SRT dose were associated with FFBF. Pre-SRT PSA, GS, SVI, surgical margins, and ADT use were associated with DM, whereas EPE and SRT dose were not. The nomogram concordance indices were 0.68 (FFBF) and 0.74 (DM). Conclusion Early SRT at low PSA levels after RP is associated with improved FFBF and DM rates. Contemporary nomograms can estimate individual patient outcomes after SRT in the modern era.
Paraprotein–Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance
Rosner, Mitchell H. , Edeani, Amaka , Yanagita, Motoko , Forum, for the American Society of Nephrology Onco-Nephrology, Rosner, Mitchell H. , Glezerman, Ilya G , Leung, Nelson , Forum, for the American Society of Nephrology Onco-Nephrology

Clinical Journal of the American Society of Nephrology | August 15, 2016 | Volume: 11 | Issue: 12 | Pages: 2280-2287

10.2215/cjn.02920316 | PMID 27526705 Get It

Paraprotein–related kidney disease represents a complex group of diseases caused by an abnormal paraprotein secreted by a clone of B cells. The disease manifestations range from tubulopathies, such as the Fanconi syndrome, to a spectrum of glomerular diseases that can present with varying degrees of proteinuria and renal dysfunction. Diagnosis of these diseases can be challenging because of the wide range of manifestations as well as the relatively common finding of a serum paraprotein, especially in elderly patients. Thus, renal biopsy along with detailed hematologic workup is essential to link the presence of the paraprotein to the associated renal disease. Recent advances in treatment with more effective and targeted chemotherapies, as well as stem cell transplantation, have improved the renal and overall prognosis for many of these disorders.
Central canal enhancement and the trident sign in spinal cord sarcoidosis
Zalewski, Nicholas L. , Krecke, Karl N. , Weinshenker, Brian G. , Aksamit, Allen J. , Conway, Brittani L., McKeon, Andrew , Flanagan, Eoin P. , Flanagan, E P , Weinshenker, Brian G , McKeon, Andrew

Neurology | August 15, 2016 | Volume: 87 | Issue: 7 | Pages: 743-744

10.1212/wnl.0000000000002992 | PMID 27527540 Get It

Author response: BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer
Weaver, Robbyn L, Limzerwala, Jazeel F. , Naylor, Ryan M. , Deursen, Jan M. van , Jeganathan, Karthik B. , Baker, Darren J.

No container title available | August 15, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.16620.036 Get It